Creo Medical Group (LON:CREO) Trading Down 2.9% – Time to Sell?

Creo Medical Group PLC (LON:CREO) dropped 2.9% on Wednesday . The company traded as low as GBX 12.75 ($0.16) and last traded at GBX 12.75 ($0.16). Approximately 360,594 shares traded hands during trading, a decline of 50% from the average daily volume of 715,357 shares. The stock had previously closed at GBX 13.13 ($0.17).

Creo Medical Group Stock Performance

The company has a current ratio of 3.24, a quick ratio of 2.19 and a debt-to-equity ratio of 29.96. The firm has a market capitalization of £51.54 million, a price-to-earnings ratio of -2.02 and a beta of 0.86. The stock has a fifty day moving average price of GBX 16.11 and a 200-day moving average price of GBX 18.97.

Insiders Place Their Bets

In other news, insider Richard John Rees purchased 4,712 shares of Creo Medical Group stock in a transaction on Thursday, January 16th. The shares were purchased at an average cost of GBX 19 ($0.24) per share, for a total transaction of £895.28 ($1,152.67). Corporate insiders own 22.43% of the company’s stock.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.